2021 ASCO Annual Meeting - Presentations on balstilimab differentiation and AGEN2373

June 4 - June 8, 2021


  • Title: Differentiated Activity Profile for the PD-1 Inhibitor balstilimab

    Poster number: 5529

    Poster Session: Gynecologic Cancer

    Presenting author: Cailin Joyce, PhD

  • Title: Initial Findings of the First-in-human Phase I Study of AGEN2373, a Conditionally Active CD137 Agonist Antibody, in Patients (pts) With Advanced Solid Tumors

    Poster number: 2634

    Poster Session: Developmental Therapeutics - Immunotherapy

    Presenting author: Anthony Tolcher, MD

Supporting Materials